Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren/ Valsartan

DRUG

Telmisartan/ Ramipril

Trial Locations (1)

Novartis Investigative Site, Moscow